Skip to content
10-Q

Quarterly Report

CANTEL MEDICAL LLC

0000019446-21-000011

← back to feed
Filed
Mar 10, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Feb 28, 2021 42.27M sh
Shares Diluted Q2 2021 · Jan 31, 2021 44.07M sh
Shares Diluted Q2 2021 · Jan 31, 2021 43.52M sh
Shares Diluted Q2 2021 · Jan 31, 2020 42.56M sh
Shares Diluted Q2 2021 · Jan 31, 2020 42.39M sh
Stock Repurchased Q2 2021 · Jan 31, 2021 $2.33M
Stock Repurchased Q2 2021 · Jan 31, 2020 $3.7M
Dividends Paid Q2 2021 · Jan 31, 2021 $0
Dividends Paid Q2 2021 · Jan 31, 2020 $4.47M
Capex Q2 2021 · Jan 31, 2021 $17.01M
Capex Q2 2021 · Jan 31, 2020 $21.1M
Operating Cash Flow Q2 2021 · Jan 31, 2021 $109.75M
Operating Cash Flow Q2 2021 · Jan 31, 2020 $43.53M
Long Term Debt Q2 2021 · Jan 31, 2021 $788.45M
Long Term Debt Q2 2021 · Jul 31, 2020 $926.83M
Short Term Debt Q2 2021 · Jan 31, 2021 $22.13M
Short Term Debt Q2 2021 · Jul 31, 2020 $7.38M
Cash And Equivalents Q2 2021 · Jan 31, 2021 $243.06M
Cash And Equivalents Q2 2021 · Jul 31, 2020 $277.87M
Stockholders Equity Q2 2021 · Jan 31, 2021 $787.67M
Stockholders Equity Q2 2021 · Oct 31, 2020 $758.38M
Stockholders Equity Q2 2021 · Jul 31, 2020 $729.6M
Stockholders Equity Q2 2021 · Jan 31, 2020 $723.28M
Stockholders Equity Q2 2021 · Oct 31, 2019 $732.19M
Stockholders Equity Q2 2021 · Jul 31, 2019 $661.54M
Current Liabilities Q2 2021 · Jan 31, 2021 $234.55M
Current Liabilities Q2 2021 · Jul 31, 2020 $179.5M
Total Liabilities Q2 2021 · Jan 31, 2021 $1.26B
Total Liabilities Q2 2021 · Jul 31, 2020 $1.34B
Current Assets Q2 2021 · Jan 31, 2021 $638.04M
Current Assets Q2 2021 · Jul 31, 2020 $646.63M
Total Assets Q2 2021 · Jan 31, 2021 $2.05B
Total Assets Q2 2021 · Jul 31, 2020 $2.07B
Eps Diluted Q2 2021 · Jan 31, 2021 $0.27
Eps Diluted Q2 2021 · Jan 31, 2021 $0.84
Eps Diluted Q2 2021 · Jan 31, 2020 −$0.05
Eps Diluted Q2 2021 · Jan 31, 2020 $0.08
Eps Basic Q2 2021 · Jan 31, 2021 $0.29
Eps Basic Q2 2021 · Jan 31, 2021 $0.87
Eps Basic Q2 2021 · Jan 31, 2020 −$0.05
Eps Basic Q2 2021 · Jan 31, 2020 $0.08
Sga Expense Q2 2021 · Jan 31, 2021 $65.86M
Sga Expense Q2 2021 · Jan 31, 2021 $115.23M
Sga Expense Q2 2021 · Jan 31, 2020 $62.05M
Sga Expense Q2 2021 · Jan 31, 2020 $117.34M
Rd Expense Q2 2021 · Jan 31, 2021 $7.56M
Rd Expense Q2 2021 · Jan 31, 2021 $15.13M
Rd Expense Q2 2021 · Jan 31, 2020 $7.86M
Rd Expense Q2 2021 · Jan 31, 2020 $15.6M
Net Income Q2 2021 · Jan 31, 2021 $12.07M
Net Income Q2 2021 · Jan 31, 2021 $36.53M
Net Income Q2 2021 · Oct 31, 2020 $24.46M
Net Income Q2 2021 · Jan 31, 2020 −$2.26M
Net Income Q2 2021 · Jan 31, 2020 $3.5M
Net Income Q2 2021 · Oct 31, 2019 $5.77M
Operating Income Q2 2021 · Jan 31, 2021 $31.63M
Operating Income Q2 2021 · Jan 31, 2021 $81.98M
Operating Income Q2 2021 · Jan 31, 2020 $7.6M
Operating Income Q2 2021 · Jan 31, 2020 $22.02M
Gross Profit Q2 2021 · Jan 31, 2021 $143.48M
Gross Profit Q2 2021 · Jan 31, 2021 $290.84M
Gross Profit Q2 2021 · Jan 31, 2020 $122.24M
Gross Profit Q2 2021 · Jan 31, 2020 $238.11M
Cost Of Revenue Q2 2021 · Jan 31, 2021 $150.56M
Cost Of Revenue Q2 2021 · Jan 31, 2021 $300.22M
Cost Of Revenue Q2 2021 · Jan 31, 2020 $166.25M
Cost Of Revenue Q2 2021 · Jan 31, 2020 $307.63M
Revenue Q2 2021 · Jan 31, 2021 $294.04M
Revenue Q2 2021 · Jan 31, 2021 $591.07M
Revenue Q2 2021 · Jan 31, 2020 $288.5M
Revenue Q2 2021 · Jan 31, 2020 $545.74M